These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3659819)

  • 1. [Incorporation of 125I-UdR into K2M polymorphocellular sarcoma in LEW/CUB rats--radiometry in situ and in vitro (1st report)].
    Dostál M; Chmelar V; Kousalová M; Resl M; Vodicka I; Jukl M; Volenec K
    Sb Lek; 1987 Jul; 89(7):212-22. PubMed ID: 3659819
    [No Abstract]   [Full Text] [Related]  

  • 2. Reutilization of 125I-UdR during growth of a solid mammary carcinoma: implications for the 125I-UdR loss technique.
    Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
    Strahlenther Onkol; 1987 Nov; 163(11):723-8. PubMed ID: 3686335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of in vitro behaviour characterizing cells of spontaneously metastasizing K2M rat sarcoma.
    Veselý P; Chaloupková A; Urbanec P; Urbancová H; Bohác L; Krchnáková E; Franc F; Sprincl L; Vousden K; Moss R
    Folia Biol (Praha); 1987; 33(5):307-24. PubMed ID: 3500878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F; Yaakubovicz M; Witz IP
    J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract]   [Full Text] [Related]  

  • 5. [Positive tumor demonstration using 131 iodine desoxyuridine following partial synchronization].
    Wayss K; Mattern J; Schuhmacher J; Volm M
    Verh Dtsch Ges Pathol; 1974; 58():510. PubMed ID: 4460530
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of radio- and chemotoxic effects of 125I-UdR on tumour growth and host survival.
    Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
    Radiat Environ Biophys; 1985; 24(3):219-26. PubMed ID: 4034927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity.
    Le Mevel BP; Oldham RK; Wells SA; Herberman RB
    J Natl Cancer Inst; 1973 Nov; 51(5):1551-8. PubMed ID: 4797027
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell loss from several types of solid murine tumour: comparison of 125I-iododeoxyuridine and tritiated thymidine methods.
    Begg AC
    Cell Tissue Kinet; 1977 Sep; 10(5):409-27. PubMed ID: 922795
    [No Abstract]   [Full Text] [Related]  

  • 9. Localized incorporation of iododeoxyuridine from polycation-complexed iododeoxycytidylic acid into DNA of several murine and hamster tumors.
    Woodman RJ
    Cancer Res; 1968 Oct; 28(10):2007-16. PubMed ID: 5696932
    [No Abstract]   [Full Text] [Related]  

  • 10. In vio replication and antimetabolite incorporation by coexistent normal and autogenous tumor cells.
    Post J; Hoffman J
    Br J Cancer; 1968 Mar; 22(1):149-54. PubMed ID: 5643000
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell transfer studies on the persistence of homograft sensitivity in the mouse: in vitro and in vivo correlates of the activity of sensitised lymph node cells.
    Warren J; Gowland G
    J Pathol; 1974 Oct; 114(2):101-11. PubMed ID: 4613807
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrostimulation of rat callus cells and human lymphocytes in vitro.
    Aro H; Eerola E; Aho AJ; Penttinen R
    J Orthop Res; 1984; 2(1):23-31. PubMed ID: 6491795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double label radioactivity per cell (RC) analysis in vivo: rapid cytokinetic analysis of the KHT sarcoma.
    Xue SB; Paiiavicini MG; Gray JW
    Shi Yan Sheng Wu Xue Bao; 1985 Jun; 18(2):215-24. PubMed ID: 3835752
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thyroid gland function during regression of experimental tumors under conditions of hypothalamic stimulation].
    Bordiushkov IuN; Gashnikova LI
    Vopr Onkol; 1973; 19(6):65-8. PubMed ID: 4205006
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo distribution of 67gallium and 111Indium complexes with transferrin: uptake by DS sarcoma tumors.
    Anghileri LJ; Ottaviani M; Raynaud C
    J Nucl Med Allied Sci; 1983; 27(1):17-20. PubMed ID: 6864323
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of cyclophosphamide on serum ceruloplasmin oxidase activity in sarcoma bearing rats.
    Abreu LA; Abreu RR
    Arch Geschwulstforsch; 1981; 51(5):394-7. PubMed ID: 7305614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the mechanism by which anticoagulation with warfarin inhibits blood-borne metastases.
    Brown JM
    Cancer Res; 1973 Jun; 33(6):1217-24. PubMed ID: 4718672
    [No Abstract]   [Full Text] [Related]  

  • 18. The estimation of human tumors sensitivity to cytostatic treatment. II. The influencing of 125-I iododeoxyuridine incorporation by cytostatics in experimental tumors.
    Andrýsek O; Motycka K; Dvorák O; Jandová A; Stránská E
    Neoplasma; 1969; 16(1):57-61. PubMed ID: 5786510
    [No Abstract]   [Full Text] [Related]  

  • 19. A cell kinetic method for the mitotic selection of treated G2 cells.
    Schneiderman MH; Schneiderman GS; Rusk CM
    Cell Tissue Kinet; 1983 Jan; 16(1):41-9. PubMed ID: 6825155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the effect of temperature and pH change on the in-vitro incorporation of nucleic acid precursors in malignant tumors and normal tissues].
    Wüst GP
    Verh Dtsch Ges Inn Med; 1971; 77():746-8. PubMed ID: 4346180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.